An evaluation of cabotegravir for HIV treatment and prevention
Author:
Affiliation:
1. Division of Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy
2. School of Medicine, Vita–Salute San Raffaele University, Milan, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1843635
Reference57 articles.
1. Targeting early infection to prevent HIV-1 mucosal transmission
2. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
3. Long-acting injectable therapy
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication;International Journal of Molecular Sciences;2024-03-25
2. Chiral LC method development: Stereo-selective separation, characterization, and determination of cabotegravir and related RS, RR, and SS isomeric impurities on coated cellulose-based chiral stationary phase by HILIC-LC and LC-MS;Journal of Pharmaceutical and Biomedical Analysis;2023-01
3. Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV;Expert Review of Anti-infective Therapy;2022-06-13
4. Disparities In Uptake Of HIV Pre-Exposure Prophylaxis Among California Medicaid Enrollees;Health Affairs;2022-03-01
5. Cabotegravir: A novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection;Drugs of Today;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3